Skip to content
The People's CodeSearch
Menu

Changes to the Code

S. 5736 · Hemp Guardrails Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

7 U.S.C. § 1639o Definitions

+8 −01 of 8 shown
More for 7 U.S.C. § 1639o
Read § 1639oOnly this section
8 changes the bill asks for here, 1 carried out
  1. Not carried out:

    in subparagraph (A), by striking 0.3 and inserting 1.0;

    “0.3” isn't in § 1639o(4)(A) in the Code as we have it. The law may have changed since the bill was drafted.

    Technical detail“0.3” not found in /us/usc/t7/s1639o/4/A
  2. Not carried out:

    by striking 0.3 and inserting 1.0; and

    The bill points to clause (i) of § 1639o(4)(C), which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no clause (i) in /us/usc/t7/s1639o/4/C
  3. Not carried out:

    by striking or after the semicolon;

    The bill points to clause (i) of § 1639o(4)(C), which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no clause (i) in /us/usc/t7/s1639o/4/C
  4. Not carried out:

    by striking subclauses (II) and (III); and

    The bill points to clause (ii) of § 1639o(4)(C), which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no clause (ii) in /us/usc/t7/s1639o/4/C
  5. Not carried out:

    by striking containing— and all that follows through cannabinoids in subclause (I) and inserting containing cannabinoids; and

    We can't read how this instruction is worded yet, so it isn't shown in the text.

    Technical detailno-pattern: striking QTEXT and all that follows through QTEXT in subclause (X) and inserting QTEXT; and
  6. Not carried out:

    in subclause (I), by adding or after the semicolon at the end; and

    The bill points to clause (iv) of § 1639o(4)(C), which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no clause (iv) in /us/usc/t7/s1639o/4/C
  7. Not carried out:

    by striking subclauses (II) and (III) and inserting the following:(II) more than trace amounts of restricted cannabinoids.; and

    The bill points to clause (iv) of § 1639o(4)(C), which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no clause (iv) in /us/usc/t7/s1639o/4/C
  8. Carried out:

    by adding at the end the following:(D) Restricted cannabinoids.— For purposes of subparagraph (C)(iv), the term “restricted cannabinoids”— (i) means cannabinoids, other than delta-9 tetrahydrocannabinol, that produce intoxication or impairment in humans through agonism of the cannabinoid CB1 receptor, including …

§ 1639o(1)–(3)

§ 1639o. Definitions

In this subchapter:

(1) Hemp The term “hemp” means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.

(D) [inserted: Restricted cannabinoids.—] [inserted: For purposes of subparagraph (C)(iv), the term “restricted cannabinoids”—]

(i) [inserted: means cannabinoids, other than delta-9 tetrahydrocannabinol, that produce intoxication or impairment in humans through agonism of the cannabinoid CB1 receptor, including delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, hexahydrocannabinol (HHC), and tetrahydrocannabinol acetate (THC-O-acetate), together with their isomers, analogs, esters, ethers, and salts; and]

(ii) [inserted: does not include cannabidiol (CBD), cannabinol (CBN), cannabigerol (CBG), cannabichromene (CBC), cannabidivarin (CBDV), tetrahydrocannabivarin (THCV), or delta-9 tetrahydrocannabinol.]

(E) [inserted: Unfinished hemp-cannabinoid ingredients.—] [inserted: Notwithstanding any other provision of this paragraph, an unfinished hemp-cannabinoid ingredient (as defined in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321)) shall be considered hemp under this subtitle.]

(2) Indian tribe The term “Indian tribe” has the meaning given the term in section 5304 of title 25.

(3) Secretary The term “Secretary” means the Secretary of Agriculture.

Rest of § 1639o unchanged ·

7 U.S.C. § 1639p State and tribal plans

+2 −2Shown
More for 7 U.S.C. § 1639p
Read § 1639pOnly this section
2 changes the bill asks for here, 2 carried out
  1. Carried out:

    in subsection (a)(2)(A)(ii), by striking delta-9 tetrahydrocannabinol concentration and inserting total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid); and

  2. Carried out:

    in subsection (e)(2)(A)(iii), by striking delta-9 tetrahydrocannabinol concentration of more than 0.3 percent and inserting total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid) of more than 1.0 percent.

§ 1639p(a)(2)(A)shall only be required to include—(i)–(iii)

Start of § 1639p to (a)(2)(A) unchanged ·

(i) a practice to maintain relevant information regarding land on which hemp is produced in the State or territory of the Indian tribe, including a legal description of the land, for a period of not less than 3 calendar years;

(ii) a procedure for testing, using post-decarboxylation or other similarly reliable methods, [struck: delta-9][inserted: total] [struck: tetrahydrocannabinol][inserted: tetrahydrocannabinols] concentration [inserted: (including tetrahydrocannabinolic acid) ]levels of hemp produced in the State or territory of the Indian tribe;

(iii) a procedure for the effective disposal of—

(I) plants, whether growing or not, that are produced in violation of this subchapter; and

§ 1639p(e)(2)Negligent violation(A)–(B)

(a)(2)(A)(iii)(II)–(e)(2)(A)(i) unchanged ·

(ii) failing to obtain a license or other required authorization from the State department of agriculture or Tribal government, as applicable; or

(iii) producing Cannabis sativa L. with a [struck: delta-9][inserted: total] [struck: tetrahydrocannabinol][inserted: tetrahydrocannabinols] concentration [inserted: (including tetrahydrocannabinolic acid) ]of more than [struck: 0][inserted: 1].[struck: 3][inserted: 0] percent on a dry weight basis.

(B) Corrective action plan A hemp producer described in subparagraph (A) shall comply with a plan established by the State department of agriculture or Tribal government, as applicable, to correct the negligent violation, including—

(i) a reasonable date by which the hemp producer shall correct the negligent violation; and

Rest of § 1639p unchanged ·

7 U.S.C. § 1639q Department of Agriculture

+1 −1Shown
More for 7 U.S.C. § 1639q
Read § 1639qOnly this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 297C(a)(2)(B) of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639q(a)(2)(B)) is amended by striking delta-9 tetrahydrocannabinol concentration and inserting total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid).

§ 1639q(a)(2)Content(A)–(C)

Start of § 1639q to (a)(2) unchanged ·

(A) a practice to maintain relevant information regarding land on which hemp is produced in the State or territory of the Indian tribe, including a legal description of the land, for a period of not less than 3 calendar years;

(B) a procedure for testing, using post-decarboxylation or other similarly reliable methods, [struck: delta-9][inserted: total] [struck: tetrahydrocannabinol][inserted: tetrahydrocannabinols] concentration [inserted: (including tetrahydrocannabinolic acid) ]levels of hemp produced in the State or territory of the Indian tribe;

(C) a procedure for the effective disposal of—

(i) plants, whether growing or not, that are produced in violation of this subchapter; and

Rest of § 1639q unchanged ·

21 U.S.C. § 321 Definitions; generally

+60 −01 of 3 shown
More for 21 U.S.C. § 321
Read § 321Only this section
3 changes the bill asks for here, 1 carried out
  1. Not carried out:

    in paragraph (s), in the matter preceding subparagraph (1), by striking food (including any substance and inserting food (including industrial hemp intended for human or animal use and hemp seed, hemp seed oil, or hempseed protein not containing cannabinoids, any substance;

    The bill points to paragraph (s) of § 321, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (s) in /us/usc/t21/s321
  2. Not carried out:

    in paragraph (rr), by adding at the end the following:(6) The term “tobacco product” does not include a hemp-derived cannabinoid product.; and

    The bill points to paragraph (rr) of § 321, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (rr) in /us/usc/t21/s321
  3. Carried out:

    by adding at the end the following:(tt) The term “hemp-derived cannabinoid product”— (1) except as otherwise provided in subparagraph (2), has the meaning given the term in section 297A of the Agricultural Marketing Act of 1946; (2) may include an intermediate hemp-derived cannabinoid product (as defined in …

§ 321(ss)–(ww)

Start of § 321 to (ss) unchanged ·

(1) an infant formula; or

(2) a medical food, as defined in section 360ee(b)(3) of this title.

(tt) [inserted: The term “hemp-derived cannabinoid product”—]

(1) [inserted: except as otherwise provided in subparagraph (2), has the meaning given the term in section 297A of the Agricultural Marketing Act of 1946;]

(2) [inserted: may include an intermediate hemp-derived cannabinoid product (as defined in section 297A of the Agricultural Marketing Act of 1946) only in such cases as the Secretary determines appropriate;]

(3) [inserted: includes a hemp-derived cannabinoid dietary supplement;]

(4) [inserted: may include ingestibles, beverages, oral tinctures and sublinguals, capsules and tablets, inhalables (other than raw floral hemp material, smokable hemp flower, or pre-roll material that is intended for inhalation), and topicals and transdermals; and]

(5) [inserted: does not include—]

(A) [inserted: a drug that is subject to the requirements of chapter V or section 351 of the Public Health Service Act;]

(B) [inserted: a device that is subject to the requirements of chapter V; or]

(C) [inserted: an unfinished hemp-cannabinoid ingredient.]

(uu) [inserted: The term “hemp-derived cannabinoid dietary supplement”—]

(1) [inserted: means a dietary supplement that—]

(A) [inserted: contains one or more ingredients that are derived from hemp;]

(B) [inserted: contains one or more cannabinoids; and]

(C) [inserted: is for ingestion in tablet, capsule, softgel, gelcap, powder, gummy, chew, lozenge, tincture, oil, spray, strip, or liquid form;]

(2) [inserted: is not marketed for its impairing effects; and]

(3) [inserted: does not include—]

(A) [inserted: any product for inhalation, application to the skin, or transdermal absorption;]

(B) [inserted: any product containing raw floral hemp material, an unfinished hemp-cannabinoid ingredient, or work-in-process materials;]

(C) [inserted: any product containing industrial hemp;]

(D) [inserted: any product containing hemp seed, hemp seed oil, or hempseed protein not containing cannabinoids; or]

(E) [inserted: any product containing any cannabinoid not found in, or capable of being produced in, the hemp plant.]

(vv) [inserted: The term “hemp” has the meaning given such term in section 297A of the Agricultural Marketing Act of 1946.]

(ww) [inserted: The term “unfinished hemp-cannabinoid ingredient” means an oil, extract, concentrate, distillate, or other intermediate substance that—]

(1) [inserted: meets the criteria specified in subparagraphs (A) through (D) of section 297A(1) of the Agricultural Marketing Act of 1946 to be considered hemp, except that such substance may contain a concentration of total tetrayhdrocannabinol that exceeds 1 percent during processing, on the conditions that such substance—]

(A) [inserted: remains exclusively with actors or entities lawfully permitted to manufacture hemp-derived cannabinoid products under this Act; and]

(B) [inserted: is not offered for retail sale;]

(2) [inserted: is not for consumer use;]

(3) [inserted: is not marketed, sold, distributed, or shipped to any actors or entities other than actors or entities lawfully permitted to manufacture hemp-derived cannabinoid products under this Act;]

(4) [inserted: is not a finished hemp product; and]

(5) [inserted: is produced solely for incorporation into a finished cannabinoid product through further processing.]

21 U.S.C. § 331 Prohibited acts

+13 −01 of 9 shown
More for 21 U.S.C. § 331
Read § 331Only this section
9 changes the bill asks for here, 1 carried out
  1. Not carried out:

    by inserting hemp-derived cannabinoid product, after tobacco product, each place it appears in paragraphs (a), (b), (c), (g), (h), and (k);

    The bill points to paragraph (a) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (a) in /us/usc/t21/s331
  2. Not carried out:

    by inserting hemp-derived cannabinoid product, after tobacco product, each place it appears in paragraphs (a), (b), (c), (g), (h), and (k);

    The bill points to paragraph (b) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (b) in /us/usc/t21/s331
  3. Not carried out:

    by inserting hemp-derived cannabinoid product, after tobacco product, each place it appears in paragraphs (a), (b), (c), (g), (h), and (k);

    The bill points to paragraph (c) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (c) in /us/usc/t21/s331
  4. Not carried out:

    by inserting hemp-derived cannabinoid product, after tobacco product, each place it appears in paragraphs (a), (b), (c), (g), (h), and (k);

    The bill points to paragraph (g) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (g) in /us/usc/t21/s331
  5. Not carried out:

    by inserting hemp-derived cannabinoid product, after tobacco product, each place it appears in paragraphs (a), (b), (c), (g), (h), and (k);

    The bill points to paragraph (h) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (h) in /us/usc/t21/s331
  6. Not carried out:

    by inserting hemp-derived cannabinoid product, after tobacco product, each place it appears in paragraphs (a), (b), (c), (g), (h), and (k);

    The bill points to paragraph (k) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (k) in /us/usc/t21/s331
  7. Not carried out:

    by striking 510 or 905 and inserting 510, 905, or 1103; and

    The bill points to paragraph (p) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (p) in /us/usc/t21/s331
  8. Not carried out:

    by striking or 905(j) and inserting 905(j), or 1103; and

    The bill points to paragraph (p) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (p) in /us/usc/t21/s331
  9. Carried out:

    by adding at the end the following:(jjj) (1) The introduction or delivery for introduction into interstate commerce of any food to which has been added a hemp-derived cannabinoid product, unless the finished product complies with the requirements for food under chapter IV and for hemp-derived cannabinoid products …

§ 331(hhh)–(jjj)

Start of § 331 to (ggg)(2) unchanged ·

(hhh) The failure to register or submit listing information in accordance with section 364c of this title.

(iii) The refusal or failure to follow an order under section 364g of this title.

(jjj)

(1) [inserted: The introduction or delivery for introduction into interstate commerce of any food to which has been added a hemp-derived cannabinoid product, unless the finished product complies with the requirements for food under chapter IV and for hemp-derived cannabinoid products under chapter XI.]

(2) [inserted: The introduction or delivery for introduction into interstate commerce of a hemp-derived cannabinoid product that is not derived exclusively from hemp cultivated in the United States, processed within the United States, and finished, packaged, and labeled within the United States.]

(3) [inserted: The sale of a hemp-derived cannabinoid product to any person younger than 21 years of age.]

(4) [inserted: The possession or consumption of a hemp-derived cannabinoid product by any person younger than 21 years of age.]

(5) [inserted: The sale of a hemp-derived cannabinoid product that does not comply with the child-resistant packaging requirements established by regulations promulgated under section 1103.]

(6) [inserted: The introduction or delivery for introduction into interstate commerce of a hemp-derived cannabinoid product intended for human consumption that contains, or purports to contain, raw floral hemp material, smokable flower, or pre-roll material that is intended for inhalation.]

21 U.S.C. § 334 Seizure

+1 −11 of 2 shown
More for 21 U.S.C. § 334
Read § 334Only this section
2 changes the bill asks for here, 1 carried out
  1. Carried out:

    Section 304(a)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 334) is amended by striking the period at the end and adding the following: Any adulterated or misbranded hemp-derived cannabinoid product..

  2. Not carried out:

    Section 304(a)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 334) is amended by striking the period at the end and adding the following: Any adulterated or misbranded hemp-derived cannabinoid product..

    We can't read how this instruction is worded yet, so it isn't shown in the text.

    Technical detailno-pattern: adding the following: QTEXT.

§ 334(a)

§ 334. Seizure

(a) Grounds and jurisdiction

(1) Any article of food, drug, or cosmetic that is adulterated or misbranded when introduced into or while in interstate commerce or while held for sale (whether or not the first sale) after shipment in interstate commerce, or which may not, under the provisions of section 331(ll), 344, or 355 of this title, be introduced into interstate commerce, shall be liable to be proceeded against while in interstate commerce, or at any time thereafter, on libel of information and condemned in any district court of the United States or United States court of a Territory within the jurisdiction of which the article is found. No libel for condemnation shall be instituted under this chapter, for any alleged misbranding if there is pending in any court a libel for condemnation proceeding under this chapter based upon the same alleged misbranding, and not more than one such proceeding shall be instituted if no such proceeding is so pending, except that such limitations shall not apply (A) when such misbranding has been the basis of a prior judgment in favor of the United States, in a criminal, injunction, or libel for condemnation proceeding under this chapter, or (B) when the Secretary has probable cause to believe from facts found, without hearing, by him or any officer or employee of the Department that the misbranded article is dangerous to health, or that the labeling of the misbranded article is fraudulent, or would be in a material respect misleading to the injury or damage of the purchaser or consumer. In any case where the number of libel for condemnation proceedings is limited as above provided the proceeding pending or instituted shall, on application of the claimant, seasonably made, be removed for trial to any district agreed upon by stipulation between the parties, or, in case of failure to so stipulate within a reasonable time, the claimant may apply to the court of the district in which the seizure has been made, and such court (after giving the United States attorney for such district reasonable notice and opportunity to be heard) shall by order, unless good cause to the contrary is shown, specify a district of reasonable proximity to the claimant’s principal place of business, to which the case shall be removed for trial.

(2) The following shall be liable to be proceeded against at any time on libel of information and condemned in any district court of the United States or United States court of a Territory within the jurisdiction of which they are found: (A) Any drug that is a counterfeit drug, (B) Any container of a counterfeit drug, (C) Any punch, die, plate, stone, labeling, container, or other thing used or designed for use in making a counterfeit drug or drugs, (D) Any adulterated or misbranded device, (E) Any adulterated or misbranded tobacco product, (F) Any device that is a counterfeit device, (G) Any container, packaging, or labeling of a counterfeit device, and (H) Any punch, die, plate, stone, labeling, container, or other thing used or designed for use in making a counterfeit device or devices[struck: .]

(3)

(A) Except as provided in subparagraph (B), no libel for condemnation may be instituted under paragraph (1) or (2) against any food which—

Rest of § 334 unchanged ·

21 U.S.C. § 375 Publicity

+1 −1Shown
More for 21 U.S.C. § 375
Read § 375Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 705(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 375(b)) is amended by inserting hemp-derived cannabinoid products, after tobacco products,.

§ 375(a)–(b)

§ 375. Publicity

(a) Reports The Secretary shall cause to be published from time to time reports summarizing all judgments, decrees, and court orders which have been rendered under this chapter, including the nature of the charge and the disposition thereof.

(b) Information regarding certain goods The Secretary may also cause to be disseminated information regarding food, drugs, devices, tobacco products, [inserted: hemp-derived cannabinoid products, ]or cosmetics in situations involving, in the opinion of the Secretary, imminent danger to health or gross deception of the consumer. Nothing in this section shall be construed to prohibit the Secretary from collecting, reporting, and illustrating the results of the investigations of the Department.

21 U.S.C. § 379a Presumption of existence of jurisdiction

+1 −1Shown
More for 21 U.S.C. § 379a
Read § 379aOnly this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 709 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379a) is amended by inserting hemp-derived cannabinoid product, after tobacco product,.

§ 379a

§ 379a. Presumption of existence of jurisdiction

In any action to enforce the requirements of this chapter respecting a device, tobacco product, [inserted: hemp-derived cannabinoid product, ]food, drug, or cosmetic the connection with interstate commerce required for jurisdiction in such action shall be presumed to exist.

21 U.S.C. § 348 Food additives

Couldn't place the change
More for 21 U.S.C. § 348
Read § 348Only this section

The bill's words for this section

  1. Not carried out:

    Section 409(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 348(a)) is amended by adding at the end of the matter following paragraph (3) the following: A food bearing or containing a hemp-derived cannabinoid product that meets the requirements of chapter XI shall not, by reason of bearing or containing such a hemp-derived cannabinoid product, be considered adulterated under subparagraph (1) or (2)(C)(i) of section 402(a)..

    We can't read how this instruction is worded yet, so it isn't shown in the text.

    Technical detailno-pattern: adding at the end of the matter following paragraph (X) the following: QTEXT.

21 U.S.C. § 374 Inspection

Couldn't place the change
More for 21 U.S.C. § 374
Read § 374Only this section

The bill's words for this section

  1. Not carried out:

    Section 704(a)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 374(a)(1)) is amended, in the first sentence, in subparagraph (A), by inserting hemp-derived cannabinoid products, after tobacco products, each place it appears.

    The bill points to subparagraph (A) of § 374(a)(1), which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no subparagraph (A) in /us/usc/t21/s374/a/1

Step through the changes